Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...

Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...

Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...

Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Intel stock dropped 6% on Tuesday as investors reacted to the CEO's departure. Wall Street analysts say there's more ...

Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...

Stellantis' next CEO faces a mountain of challenges, including overpriced vehicles with little demand, EVs arriving as the ...

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...

A potential Trump administration may ease regulations for self-driving vehicles, accelerating Tesla's progress ...

Judge Kathleen McCormick described the electric car maker’s legal arguments as ‘creative’ but ‘fatally flawed’ ...